Betta Income Before Tax from 2010 to 2024

300558 Stock   49.36  3.74  7.04%   
Betta Pharmaceuticals' Income Before Tax is increasing over the years with slightly volatile fluctuation. Income Before Tax is expected to dwindle to about 311.8 M. From 2010 to 2024 Betta Pharmaceuticals Income Before Tax quarterly data regression line had arithmetic mean of  267,614,823 and r-squared of  0.22. View All Fundamentals
 
Income Before Tax  
First Reported
2015-12-31
Previous Quarter
107.2 M
Current Value
142.9 M
Quarterly Volatility
76.2 M
 
Yuan Drop
 
Covid
Check Betta Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Betta Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 32.1 M, Selling General Administrative of 632.6 M or Total Revenue of 1.4 B, as well as many indicators such as . Betta financial statements analysis is a perfect complement when working with Betta Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Betta Pharmaceuticals Technical models . Check out the analysis of Betta Pharmaceuticals Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Betta Stock

Betta Pharmaceuticals financial ratios help investors to determine whether Betta Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Betta with respect to the benefits of owning Betta Pharmaceuticals security.